BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 22448531)

  • 1. Vesiculobullous skin reaction temporally related to firocoxib treatment in a white rhinoceros (Ceratotherium simum).
    Stringer EM; De Voe RS; Linder K; Troan B; McCalla-Martin A; Loomis MR
    J Zoo Wildl Med; 2012 Mar; 43(1):186-9. PubMed ID: 22448531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of firocoxib in the management of canine osteoarthritis under field conditions.
    Hanson PD; Brooks KC; Case J; Conzemius M; Gordon W; Schuessler J; Shelley B; Sifferman R; Drag M; Alva R; Bell L; Romano D; Fleishman C
    Vet Ther; 2006; 7(2):127-40. PubMed ID: 16871495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of oral administration of firocoxib for the management of musculoskeletal pain and lameness associated with osteoarthritis in horses.
    Orsini JA; Ryan WG; Carithers DS; Boston RC
    Am J Vet Res; 2012 May; 73(5):664-71. PubMed ID: 22533398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term efficacy and safety of firocoxib in the treatment of dogs with osteoarthritis.
    Autefage A; Palissier FM; Asimus E; Pepin-Richard C
    Vet Rec; 2011 Jun; 168(23):617. PubMed ID: 21642297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerance of firocoxib in dogs with osteoarthritis during 90 days.
    Lecoindre O; Pepin-Richard C
    J Vet Pharmacol Ther; 2011 Apr; 34(2):190-2. PubMed ID: 21395612
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of efficacy and safety of paste formulations of firocoxib and phenylbutazone in horses with naturally occurring osteoarthritis.
    Doucet MY; Bertone AL; Hendrickson D; Hughes F; Macallister C; McClure S; Reinemeyer C; Rossier Y; Sifferman R; Vrins AA; White G; Kunkle B; Alva R; Romano D; Hanson PD
    J Am Vet Med Assoc; 2008 Jan; 232(1):91-7. PubMed ID: 18167116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical effectiveness and safety of a new NSAID, firocoxib: a 1,000 dog study.
    Ryan WG; Moldave K; Carithers D
    Vet Ther; 2006; 7(2):119-26. PubMed ID: 16871494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of firocoxib (Previcox) in geriatric dogs over a period of 90 days.
    Joubert KE
    J S Afr Vet Assoc; 2009 Sep; 80(3):179-84. PubMed ID: 20169752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CLINICAL MANAGEMENT OF BILATERAL CUTANEOUS SQUAMOUS CELL CARCINOMA OF THE HIND FEET PADS IN A SOUTHERN WHITE RHINOCEROS (CERATOTHERIUM SIMUM SIMUM).
    Greunz EM; Simon M; Lemberger K; Galateanu G; Hermes R; Leclerc A
    J Zoo Wildl Med; 2016 Jun; 47(2):645-9. PubMed ID: 27468043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Switching NSAIDs in practice: insights from the Previcox (firocoxib) Experience Trial.
    Ryan WG; Moldave K; Carithers D
    Vet Ther; 2007; 8(4):263-71. PubMed ID: 18183545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous adverse drug reaction in a dog following firocoxib treatment.
    Geum M; Ko HY; Na YJ; Kim HJ
    Vet Med Sci; 2021 Sep; 7(5):1504-1508. PubMed ID: 34021731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of force plate measurements to titrate the dosage of a new COX-2 inhibitor in lame horses.
    Back W; MacAllister CG; van Heel MC; Pollmeier M; Hanson PD
    Equine Vet J; 2009 Mar; 41(3):309-12. PubMed ID: 19469242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and safety of firocoxib after oral administration of repeated consecutive doses to neonatal foals.
    Hovanessian N; Davis JL; McKenzie HC; Hodgson JL; Hodgson DR; Crisman MV
    J Vet Pharmacol Ther; 2014 Jun; 37(3):243-51. PubMed ID: 24749691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the efficacy of firocoxib (Previcox®) and grapiprant (Galliprant®) in an induced model of acute arthritis in dogs.
    de Salazar Alcalá AG; Gioda L; Dehman A; Beugnet F
    BMC Vet Res; 2019 Aug; 15(1):309. PubMed ID: 31464629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the safety of a combination of oral administration of phenylbutazone and firocoxib in horses.
    Kivett L; Taintor J; Wright J
    J Vet Pharmacol Ther; 2014 Aug; 37(4):413-6. PubMed ID: 24354928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of firocoxib and carprofen for the treatment of dogs with osteoarthritis.
    Pollmeier M; Toulemonde C; Fleishman C; Hanson PD
    Vet Rec; 2006 Oct; 159(17):547-51. PubMed ID: 17056650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of firocoxib, carprofen and vedaprofen in a sodium urate crystal induced synovitis model of arthritis in dogs.
    Hazewinkel HA; van den Brom WE; Theyse LF; Pollmeier M; Hanson PD
    Res Vet Sci; 2008 Feb; 84(1):74-9. PubMed ID: 17408711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of ABT-116, an antagonist of transient receptor potential vanilloid type 1, in providing analgesia for dogs with chemically induced synovitis.
    Cathcart CJ; Johnston SA; Reynolds LR; Al-Nadaf S; Budsberg SC
    Am J Vet Res; 2012 Jan; 73(1):19-26. PubMed ID: 22204284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenylbutazone pharmacokinetics in southern white rhinoceros (Ceratotherium simum simum) after oral administration.
    Houck EL; Papich MG; Delk KW
    J Vet Pharmacol Ther; 2022 Mar; 45(2):196-202. PubMed ID: 34894412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and management of a patent urachus in a white rhinoceros calf (Ceratotherium simum simum).
    Langan J; Ramsay E; Schumacher J; Chism T; Adair S
    J Zoo Wildl Med; 2001 Mar; 32(1):118-22. PubMed ID: 12790407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.